Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms
暂无分享,去创建一个
[1] J. Sunil. Pharmaceutical Dosage Forms: Tablets. Vol. 1. , 1990 .
[2] A. Dahan,et al. Head-To-Head Comparison of Different Solubility-Enabling Formulations of Etoposide and Their Consequent Solubility-Permeability Interplay. , 2015, Journal of pharmaceutical sciences.
[3] Naveen Chella,et al. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan , 2015, European Journal of Drug Metabolism and Pharmacokinetics.
[4] J. Sousa,et al. Role of Cellulose Ether Polymers on Ibuprofen Release from Matrix Tablets , 2005, Drug development and industrial pharmacy.
[5] A. Lamprecht,et al. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation. , 2012, International journal of pharmaceutics.
[6] M. Niemi,et al. Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.
[7] D. Law,et al. Influence of solid phase and formulation processing on stability of Abbott-232 tablet formulations. , 2006, Journal of pharmaceutical sciences.
[8] C M Ji,et al. Guar Gum as Potential Film Coating Material for Colon-specific Delivery of Fluorouracil , 2009, Journal of biomaterials applications.
[9] H. Junginger,et al. Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on the enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles , 1996 .
[10] Shirui Mao,et al. Elucidation of release characteristics of highly soluble drug trimetazidine hydrochloride from chitosan-carrageenan matrix tablets. , 2013, Journal of pharmaceutical sciences.
[11] A. Dahan,et al. Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] S. B. Tiwari,et al. Application of Ethylcellulose Coating to Hydrophilic Matrices: A Strategy to Modulate Drug Release Profile and Reduce Drug Release Variability , 2014, AAPS PharmSciTech.
[13] G. Amidon,et al. The solubility-permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation. , 2011, Molecular pharmaceutics.
[14] P. Nagadivya. Effect of various binding agents on tablet hardness and release rate profiles of diclofenac sodium tablets , 2016 .
[15] J. van Humbeeck,et al. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings. , 2015, Molecular pharmaceutics.
[16] S. Moghimi,et al. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. , 2012, Maturitas.
[17] R. Manzo,et al. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] Han‐Gon Choi,et al. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change , 2011, Drug delivery.
[19] I. Wilding,et al. In Vitro and in Vivo Pharmacoscintigraphic Evaluation of Ibuprofen Hypromellose and Gelatin Capsules , 2004, Pharmaceutical Research.
[20] A. Bernkop‐Schnürch,et al. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. , 2003, International journal of pharmaceutics.
[21] Margareth R. C. Marques. Enzymes in the Dissolution Testing of Gelatin Capsules , 2014, AAPS PharmSciTech.
[22] Hong Liu,et al. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation. , 2007, International journal of pharmaceutics.
[23] G. Amidon,et al. Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir. , 2010, Molecular pharmaceutics.
[24] Lawrence X. Yu,et al. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations. , 2010, Molecular pharmaceutics.
[25] G. Amidon,et al. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[26] Li Sheng,et al. Application of physiologically based pharmacokinetic modeling in the prediction of pharmacokinetics of bicyclol controlled-release formulation in human. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[27] Changquan Calvin Sun,et al. A formulation strategy for solving the overgranulation problem in high shear wet granulation. , 2014, Journal of pharmaceutical sciences.
[28] S. Schwendeman,et al. Development and In Vitro-In Vivo Evaluation of Fenretinide-Loaded Oral Mucoadhesive Patches for Site-Specific Chemoprevention of Oral Cancer , 2011, Pharmaceutical Research.
[29] M. Aulton,et al. Pharmaceutical Coating Technology , 1995 .
[30] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[31] A. Dahan,et al. The solubility-permeability interplay and oral drug formulation design: Two heads are better than one. , 2016, Advanced drug delivery reviews.
[32] P. Ravaux,et al. Enzymatically degraded Eurylon 6 HP‐PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients , 2010, The Journal of pharmacy and pharmacology.
[33] H. Lieberman,et al. Pharmaceutical dosage forms : tablets , 1980 .
[34] A. Streubel,et al. Understanding and Predicting Drug Delivery from Hydrophilic Matrix Tablets Using the “Sequential Layer” Model , 2002, Pharmaceutical Research.
[35] C. Samyn,et al. In Vivo Evaluation of a Colon-Specific Drug Delivery System: An Absorption Study of Theophylline from Capsules Coated with Azo Polymers in Rats , 1995, Pharmaceutical Research.
[36] A. Dahan,et al. The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble Drugs , 2012, The AAPS Journal.
[37] P. Langguth,et al. Oral Solid Dosage Form Disintegration Testing - The Forgotten Test. , 2015, Journal of pharmaceutical sciences.
[38] Leslie Z. Benet,et al. Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.
[39] W. Roediger,et al. Colonic bicarbonate output as a test of disease activity in ulcerative colitis. , 1984, Journal of clinical pathology.
[40] L. S. Taylor,et al. Phase separation kinetics in amorphous solid dispersions upon exposure to water. , 2015, Molecular pharmaceutics.
[41] M. Z. Khan,et al. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[42] S. Itai,et al. An easy-to-use approach for determining the disintegration ability of disintegrants by analysis of available surface area. , 2013, International journal of pharmaceutics.
[43] P. Verma,et al. Controlled Porosity Solubility Modulated Osmotic Pump Tablets of Gliclazide , 2014, AAPS PharmSciTech.
[44] R. Löbenberg,et al. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[45] G. Amidon,et al. The fraction dose absorbed, in humans, and high jejunal human permeability relationship. , 2012, Molecular pharmaceutics.
[46] S. A. Sande,et al. Immersion coating of pellet cores consisting of chitosan and calcium intended for colon drug delivery. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[47] L. Emara,et al. Development of an osmotic pump system for controlled delivery of diclofenac sodium. , 2012, Drug discoveries & therapeutics.
[48] J. Hardcastle,et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. , 1988, Gut.
[49] Anders Axelsson,et al. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[50] K. Takada,et al. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[51] J. Remon,et al. Effect of the Storage Conditions on the Tensile Strength of Tablets in Relation to the Enthalpy Relaxation of the Binder , 2000, Pharmaceutical Research.
[52] John E. Hogan,et al. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets , 1987 .
[53] A. Dahan,et al. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[54] G. Amidon,et al. Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update , 2010, Expert review of clinical immunology.
[55] M S Gordon,et al. Effect of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. , 1993, Journal of pharmaceutical sciences.
[56] M. A. Alhnan,et al. A flexible-dose dispenser for immediate and extended release 3D printed tablets. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[57] A. Dahan,et al. Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulations , 2013, PloS one.
[58] Gordon L. Amidon,et al. Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs , 2009, The AAPS Journal.
[59] R. Davé,et al. Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[60] A. Dahan,et al. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[61] S. Bloomfield,et al. Investigations into the azo reducing activity of a common colonic microorganism , 1997 .
[62] W. Hinrichs,et al. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[63] Hassan Benameur,et al. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. , 2008, Advanced drug delivery reviews.
[64] G. W. Skinner,et al. Investigating the fundamental effects of binders on pharmaceutical tablet performance. , 1999, Drug development and industrial pharmacy.
[65] G. Stephenson,et al. Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approaches. , 2015, Molecular pharmaceutics.
[66] O Bley,et al. Characterization of moisture-protective polymer coatings using differential scanning calorimetry and dynamic vapor sorption. , 2009, Journal of pharmaceutical sciences.
[67] M. Hussain,et al. Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis. , 2015, Molecular pharmaceutics.
[68] R. Vivilecchia,et al. Elimination of metformin-croscarmellose sodium interaction by competition. , 2006, International journal of pharmaceutics.
[69] Sang-Min Cho,et al. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex. , 2013, International journal of pharmaceutics.
[70] L. Emara,et al. Controlled porosity osmotic pump system for the delivery of diclofenac sodium: in-vitro and in-vivo evaluation , 2014, Pharmaceutical development and technology.
[71] H. Faghihian,et al. Preparation and Characterization of Metoprolol Controlled-Release Solid Dispersions , 2006, Drug delivery.
[72] Mrudula H. Bele,et al. Effect of Sorbed Water on Disintegrant Performance of Four Brands of Polacrilin Potassium NF , 2011, AAPS PharmSciTech.
[73] A. Bernkop‐Schnürch,et al. Development and in Vivo Evaluation of an Oral Delivery System for Low Molecular Weight Heparin Based on Thiolated Polycarbophil , 2003, Pharmaceutical Research.
[74] W. Curatolo,et al. Effects of Food on a Gastrically Degraded Drug: Azithromycin Fast-Dissolving Gelatin Capsules and HPMC Capsules , 2011, Pharmaceutical Research.
[75] S. Jacob,et al. Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin? , 2007, Interactive cardiovascular and thoracic surgery.
[76] S. Mitragotri,et al. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[77] Kozo Takayama,et al. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. , 2002, Chemical & pharmaceutical bulletin.
[78] K Thoma,et al. Influence of aqueous coatings on the stability of enteric coated pellets and tablets. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[79] Y. Nishiyama,et al. Dry coating: an innovative enteric coating method using a cellulose derivative. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[80] J. Gallo,et al. A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength , 1990, Pharmaceutical Research.
[81] D. Neckers,et al. A new approach to the oral administration of insulin and other peptide drugs. , 1986, Science.
[82] G. Amidon,et al. Physiological parameters for oral delivery and in vitro testing. , 2010, Molecular pharmaceutics.
[83] S. Mathew,et al. Mucoadhesive patches of Salbutamol sulphate for unidirectional buccal drug delivery: development and evaluation. , 2011, Current drug delivery.
[84] E. Taha,et al. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma , 2011, Journal of drug targeting.
[85] I. Wilding,et al. Enteric coated HPMC capsules designed to achieve intestinal targeting. , 2002, International journal of pharmaceutics.
[86] J. Mcginity,et al. Relationship of film properties to drug release from monolithic films containing adjuvants. , 1992, Journal of pharmaceutical sciences.
[87] Smita Raghuvanshi,et al. Oral Bioavailability: Issues and Solutions via Nanoformulations , 2015, Clinical Pharmacokinetics.
[88] J. Misiewicz,et al. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. , 1989, Gut.
[89] He Wei,et al. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets. , 2007, PDA journal of pharmaceutical science and technology.
[90] Viktoriya Ioffe-Dahan,et al. The Twofold Advantage of the Amorphous Form as an Oral Drug Delivery Practice for Lipophilic Compounds: Increased Apparent Solubility and Drug Flux Through the Intestinal Membrane , 2012, The AAPS Journal.
[91] Kinam Park. Drug release mechanisms from amorphous solid dispersions. , 2015, Journal of Controlled Release.
[92] N. Urbanetz. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[93] R. Rowe. Handbook of Pharmaceutical Excipients – 7th Edition , 2013 .
[94] W. Lowenthal,et al. Mechanism of action of starch as a tablet disintegrant IV: effect of medicaments and disintegrants on mean pore diameter and porosity. , 1971, Journal of pharmaceutical sciences.
[95] W. Weitschies,et al. Development of pressure-sensitive dosage forms with a core liquefying at body temperature. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[96] S. Ben-Shabat,et al. Modern Prodrug Design for Targeted Oral Drug Delivery , 2014, Molecules.
[97] S. Travis,et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study , 2013, Gut.
[98] J. Siepmann,et al. Characterization of ethylcellulose: starch-based film coatings for colon targeting , 2009, Drug development and industrial pharmacy.
[99] Celine Valeria Liew,et al. Distribution of a viscous binder during high shear granulation--sensitivity to the method of delivery and its impact on product properties. , 2014, International journal of pharmaceutics.
[100] M. Grimm,et al. Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System. , 2015, Journal of pharmaceutical sciences.
[101] Mohammed Maniruzzaman,et al. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion. , 2011, Colloids and surfaces. B, Biointerfaces.
[102] C. Neut,et al. Novel polymeric film coatings for colon targeting: how to adjust desired membrane properties. , 2009, International journal of pharmaceutics.
[103] A. Dahan,et al. The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplay. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[104] S. Majumdar,et al. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets. , 2015, Journal of pharmaceutical sciences.
[105] G. Alderborn,et al. Moisture adsorption and tabletting. III. Effect on tablet strenght-post compaction storage time profiles , 1991 .
[106] P. Schmidt,et al. Fast dispersible ibuprofen tablets. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[107] D. Attwood,et al. An in vivo investigation into the suitability of pH dependent polymers for colonic targeting , 1993 .
[108] P. Artursson,et al. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement , 1997, Pharmaceutical Research.
[109] Jianing Zeng,et al. Development of oral extended release formulations of 6‐hydroxybuspirone , 2012, Biopharmaceutics & drug disposition.
[110] W. Lowenthal. Mechanism of action of tablet disintegrants: correlation of tablet mean pore diameter and porosity. , 1972, Journal of pharmaceutical sciences.
[111] F. Prüfert,et al. Synthesis and in vitro characterization of a novel S-protected thiolated alginate. , 2015, Carbohydrate polymers.
[112] T. Reineke,et al. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients. , 2015, Molecular pharmaceutics.
[113] M. K. Chourasia,et al. Targeting of gastrointestinal tract for amended delivery of protein/peptide therapeutics: strategies and industrial perspectives. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[114] F Theeuwes,et al. Elementary osmotic pump. , 1975, Journal of pharmaceutical sciences.
[115] T De Beer,et al. Stability and repeatability of a continuous twin screw granulation and drying system. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[116] A. Bernkop‐Schnürch,et al. Thiolated silicone oil: Synthesis, gelling and mucoadhesive properties , 2015, Acta biomaterialia.
[117] Omri Wolk,et al. New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities , 2013, Expert opinion on drug delivery.
[118] A. Dahan,et al. Predicting the solubility-permeability interplay when using cyclodextrins in solubility-enabling formulations: model validation. , 2012, International journal of pharmaceutics.
[119] A. Larsson,et al. Mechanistic modelling of drug release from a polymer matrix using magnetic resonance microimaging. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[120] J. Hardy,et al. Evaluation of an enteric‐coated delayed‐release 5‐aminosalicylic acid tablet in patients with inflammatory bowel disease , 1987, Alimentary pharmacology & therapeutics.
[121] K. Takada,et al. Importance of dissolution process on systemic availability of drugs delivered by colon delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[122] Hydrogen bond replacement--unearthing a novel molecular mechanism of surface solid dispersion for enhanced solubility of a drug for veterinary use. , 2013, International journal of pharmaceutics.
[123] Leslie Z Benet,et al. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. , 2008, Advanced drug delivery reviews.
[124] J. Dressman,et al. Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women , 1990, Pharmaceutical Research.
[125] A. Basit,et al. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release. , 2014, International journal of pharmaceutics.
[126] Ping I. Lee,et al. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[127] Gordon L Amidon,et al. A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.
[128] Matteo Cerea,et al. A novel powder coating process for attaining taste masking and moisture protective films applied to tablets. , 2004, International journal of pharmaceutics.
[129] J. Siepmann,et al. Pharmaceutical Applications of Shellac: Moisture-Protective and Taste-Masking Coatings and Extended-Release Matrix Tablets , 2003, Drug development and industrial pharmacy.
[130] S. P. Jones. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs. , 1996, Journal of drug targeting.
[131] Arik Dahan,et al. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability. , 2012, Molecular pharmaceutics.
[132] M S Gordon,et al. Effect of formulation solubility and hygroscopicity on disintegrant efficiency in tablets prepared by wet granulation, in terms of dissolution. , 1991, Journal of pharmaceutical sciences.
[133] A. Dahan,et al. Regional-Dependent Intestinal Permeability and BCS Classification: Elucidation of pH-Related Complexity in Rats Using Pseudoephedrine , 2013, The AAPS Journal.
[134] A. Rajabi-Siahboomi,et al. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[135] L. Augsburger,et al. Multiple tamping effects on drug dissolution from capsules filled on a dosing-disk type automatic capsule filling machine. , 1987, Journal of pharmaceutical sciences.
[136] C. Leopold,et al. Basic Coating Polymers for the Colon-Specific Drug Delivery in Inflammatory Bowel Disease , 2000, Drug development and industrial pharmacy.
[137] A. Dahan,et al. The solubility-permeability interplay when using cosolvents for solubilization: revising the way we use solubility-enabling formulations. , 2012, Molecular pharmaceutics.
[138] J. Folkman,et al. THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. , 1964, The Journal of surgical research.
[139] L. Lachman. Physical and chemical stability testing of tablet dosage forms. , 1965, Journal of pharmaceutical sciences.
[140] V. Shah,et al. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. , 1994, Journal of pharmaceutical sciences.
[141] A. Ohike,et al. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[142] E Shotton,et al. Effect of intragranular and extragranular disintegrating agents on particle size of disintegrated tablets. , 1976, Journal of pharmaceutical sciences.
[143] C. Samyn,et al. The Relation Between Swelling Properties and Enzymatic Degradation of Azo Polymers Designed for Colon-Specific Drug Delivery , 1994, Pharmaceutical Research.
[144] S. I. Kim,et al. Linear type azo-containing polyurethane as drug-coating material for colon-specific delivery: its properties, degradation behavior, and utilization for drug formulation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.